|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02661 QINGSONG HEALTH
Nominal 
146.400 +2.000 (+1.385%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 1,255,887 | 32.897% | 945,006 | 489,961 | 393,607 |
| Cost of Sales | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (404,658) | 702.606% | (50,418) | (45,088) | (145,834) | |
| Profit / (Loss) on Disposal | -- | -- | 282 | (51) | -- | |
| Other Non-operating Items | (54,126) | 352.218% | (11,969) | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (378,876) | -- | 7,380 | 104,535 | 6,339 | |
| Taxation | (845) | -- | 1,610 | (7,366) | (15,437) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 1,408 | (23,553) | 7,004 | |
| Non-controlling Interests | 0 | -- | 0 | 29 | 33 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (379,721) | -- | 10,398 | 73,645 | (2,061) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (6,680) | -25.062% | (8,914) | (6,363) | 1,904 |
| Depreciation & Amortisation | 4,429 | -10.975% | 4,975 | 4,668 | 5,767 |
| Directors' Emoluments | -- | -- | 6,368 | 6,127 | 6,971 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -458.000 | -- | 13.000 | -- | -- |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 1.046 | -- | -- |
| NBV per share ($) | 4.856 | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 24/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -379,721 |
| %Change | -- |
| EPS / (LPS) | RMB -4.580 |
| NBV Per Share (¥) | RMB 4.856 |